The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlpha Growth Regulatory News (ALGW)

Share Price Information for Alpha Growth (ALGW)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.20
Bid: 1.10
Ask: 1.30
Change: 0.00 (0.00%)
Spread: 0.20 (18.182%)
Open: 1.20
High: 1.20
Low: 1.20
Prev. Close: 1.20
ALGW Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment as Investment Manager/Insurance Update

28 Sep 2022 07:00

RNS Number : 9131A
Alpha Growth PLC
28 September 2022
 

 

The information communicated within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 (as in force in the United Kingdom pursuant to the European Union (Withdrawal) Act 2018). Upon the publication of this announcement, this inside information is now considered to be in the public domain

THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND IS NOT AN OFFER OF SECURITIES IN ANY JURISDICTION.

Alpha Growth plc

("Alpha" or the "Company")

Appointment as Investment Manager and Insurance Update

Alpha Growth Plc (LSE: ALGW and OTCQB: ALPGF), a leading financial services specialist in the growing longevity asset class, is very pleased to announce that its wholly owned subsidiary, Alpha Growth Management LLC (AGM) has been named investment manager of the Alpha Alternative Assets Fund (NASDAQ: AAACX).

The Alpha Alternative Assets Fund (the Fund) is an innovative longevity-based interval fund, aimed at providing main street investor access to an asset class once only available to institutional or UHNWI investors. Below are some of the key aspects of this Fund.

· The minimum investment into the Fund is set at a low level of $2,500, (1% of the amount required for the BlackOak Alpha Growth Fund) and therefore significantly increases the total addressable market for the Fund.

· The Fund expects to distribute a 5% annual dividend to investors, this means it is suitable for investors who are focussed on both income and capital appreciation - this again significantly increases the size of the addressable investment market.

· Alpha will earn a 1.5% management fee for the AUM that it manages, this is not split with any 3rd party.

· The net asset value, which is effectively the AUM that Alpha's fee will be based upon, is currently circa $7.2m - this is expected to significantly grow over the coming months and years as marketing commences.

· The Fund will generate a daily share price/net asset value which can be tracked and monitored by investors, with the NAV calculated based upon the underlying asset value that the Fund holds.

· Investors are able to buy into the fund daily and make withdrawals on a quarterly basis.

· The Fund is targeted specifically towards US resident investors

 

About the Fund

The Fund is a US focussed, continuously offered, non-diversified, closed-end management investment company that is operated as an interval fund. The Fund produces a daily NAV/share price and engages in a continuous offering of shares of beneficial interest in the Fund. The Fund is registered under the Investment Company Act of 1940 and the Securities Act of 1933 and is authorized as a Delaware statutory trust to issue an unlimited number of shares. Currently, the Fund has a net asset value of approximately $7.2 million. Investors can purchase shares daily and the Fund offers to repurchase shares to provide investors liquidity on a quarterly basis.

As part of its expansion plans, Alpha was in the process of developing its own interval fund when the opportunity to step in as investment manager of an existing fund presented itself, this allowed the Company to expedite the process, save time and costs, and quicken the route to market. Alpha's team are now focussed on repurposing the Fund to focus on longevity assets.

What is an Interval Fund?

An interval fund is very different from the Company's BlackOak Alpha Growth Fund (BOAGF), in several distinctive ways. BOAGF is a private fund with a minimum investment of $250,000 and is structured to provide tax efficient holdings of life settlements. AAACX is a registered fund, listed, and is open to investors who wish to invest small amounts. BOAGF produces a monthly NAV, while AAACX produces a daily NAV/share price. BOAGF purchases individual life settlements, while AAACX will be investing in other funds and securities with longevity asset exposure.

How will the Fund be managed and marketed?

Both funds are marketed through the registered investment advisor networks. The Company determined that it could leverage its existing relationships with Registered Investment Advisers and achieve some efficiencies as it could offer solutions to a broader investor base.

The activities of both funds will be overseen by Chad Schafer, the recently appointed Head of Affiliated Funds. The Company does not see BOAGF competing with AAACX for investors but rather sees AAACX significantly increasing the number of investors who can invest into its Funds whilst also increasing awareness of Alpha Growth Plc.

Chad Schafer, Head of Affiliated Funds, commented, "I am incredibly excited to start my Alpha career with the launch of this innovative new interval Fund, the potential to significantly and rapidly grow this new Fund was one of my key motivations for joining Alpha and I strongly believe we can create a Fund which is truly industry leading."

Chad continues, "Not only is the Fund expected to generate significant revenue in the long term and profitability for Alpha Growth as it scales but it also opens up an asset class which was previously only enjoyed by institutions and UHNWIs to a significantly wider group of investors. I believe the Alpha Alternative Assets Fund is the first registered fund of its type in the world and represents a real opportunity for significant, sustainable and profitable growth for Alpha Growth. We see this as being complimentary to BOAGF, as investors get to know longevity assets, they will seek out specific strategies and that is where we can guide them from one structure to another. The Registered Investment Adviser now has a solution for both the UHNW client who has a significant 6 figure sum to invest and who is focused on uncorrelated growth and tax efficiency, and the client who has a smaller nest egg desiring both uncorrelated income and growth."

Insurance Company Acquisition

The Directors would like to update the shareholders on the progress of its insurance company acquisition.

Alpha has successfully concluded all significant steps to complete the acquisition and now only awaits final sign off from the regulatory authority for the jurisdiction in which the Guernsey based insurance company's parent company is headquartered.

This sign-off is expected to be received shortly and, as such, Alpha has commenced the preliminary transition and take-on process with the seller and its third-party business service providers, to ensure maximum upside potential can be achieved within the shortest possible timescale.

Gobind Sahney, Executive Chairman of the Company, commented "As previously announced, the acquisition of the Guernsey based insurance company provides an excellent platform to offer extremely tax efficient insurance-based wealth management products to clients across the UK and Europe, it also provides Alpha Growth with an excellent vehicle for further value accretive acquisitions within Europe and the UK."

Gobind continued, "I'm very pleased that we have been able to launch our interval fund ahead of schedule, both this and the Guernsey acquisition are important building blocks as we deliver upon our plan to be managing over $2bn of AUM by 2025. We continue to review opportunities that fit our build and buy strategy and I look forward to sharing further information regarding this in due course."

For more information, please visit www.algwplc.com or contact the following:

 

Alpha Growth Plc

+44 (0) 20 3959 8600

Gobind Sahney, Executive Chairman 

info@algwplc.com

UK Investor Relations - Mark Treharne

ir@algwplc.com

 

About Alpha Growth plc

Specialist in Longevity Assets

Alpha Growth plc is a financial advisory business providing specialist consultancy, advisory, and supplementary services to institutional and qualified investors globally in the multi-billion dollar market of life insurance linked longevity assets. Building on its well-established network, the Alpha Growth Group has a unique position in the longevity asset services and investment business, as a listed entity with global reach. The Group's strategy is to expand its advisory and business services via acquisitions and joint ventures in the UK and the US to attain commercial scale and provide holistic solutions to alternative institutional investors who are in need of specialised skills and unique access to deploy their financial resource in longevity assets.

 

Longevity Assets and Non-correlation

As a longevity asset, it is non-correlated to the real estate, equity capital and commodity markets. Its value is a function of time because as time passes the value gets closer to the face value of the policy. Hence creating a steady increase in the net asset value of the investment. This makes it highly attractive to investors wishing to counteract volatility within an investment portfolio and add yield.

 

Note: The Company only advises on and manages Longevity Assets that originate in the USA where the structured and life settlement market is highly regulated.

 

Forward Looking Statements Disclaimer

Certain statements, beliefs and opinions in this document are forward-looking, which reflect the Company's or, as appropriate, the Company's directors' current expectations and projections about future events. By their nature, forward-looking statements involve a number of risks, uncertainties and assumptions that could cause actual results or events to differ materially from those expressed or implied by the forward-looking statements. These risks, uncertainties and assumptions could adversely affect the outcome and financial effects of the plans and events described herein. Forward-looking statements contained in this document regarding past trends or activities should not be taken as a representation that such trends or activities will continue in the future. The Company does not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. You should not place undue reliance on forward- looking statements, which speak only as of the date of this document. Readers should not treat the contents of this document as advice relating to legal, taxation or investment matters, and are to make their own assessments concerning these and other consequences, including the merits of information and the risks. Readers of this announcement are advised to conduct their own due diligence and agree to be bound by the limitations of this disclaimer.

 

Important Notice

The content of this announcement has not been approved by an authorised person within the meaning of the Financial Services and Markets Act 2000 (FSMA). This announcement has been issued by and is the sole responsibility of the Company. The information in this announcement is subject to change.

 

ENDS

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBCGDCDUDDGDR
Date   Source Headline
22nd Dec 20239:00 amRNSExpiration of Warrants
13th Dec 20237:00 amRNSAlpha International Life Receives KBRA Rating
14th Nov 20233:36 pmRNSJason Sutherland Receives Industry Recognition
9th Oct 20234:00 pmRNSHolding(s) in Company
9th Oct 20232:43 pmRNSHolding(s) in Company
29th Sep 202311:00 amRNSHalf-year Report
14th Aug 20236:29 pmRNSHolding(s) in Company
19th Jun 20237:00 amRNSResult of AGM
6th Jun 20237:00 amRNSNotice of AGM
15th May 20237:00 amRNSAcquisition of Minority Holding and Share Issuance
3rd May 20237:00 amRNSHolding(s) in Company
2nd May 20237:00 amRNS2022 Annual Report & Financial Statements
15th Mar 20237:00 amRNSWarrant Exercise and Total Voting Rights
6th Mar 20237:00 amRNS2022 Annual Recap and Fund Results
8th Feb 20234:40 pmRNSSecond Price Monitoring Extn
8th Feb 20234:35 pmRNSPrice Monitoring Extension
8th Feb 20231:10 pmRNSHolding(s) in Company
20th Jan 20232:05 pmRNSSecond Price Monitoring Extn
20th Jan 20232:00 pmRNSPrice Monitoring Extension
20th Jan 202311:05 amRNSSecond Price Monitoring Extn
20th Jan 202311:00 amRNSPrice Monitoring Extension
12th Dec 20227:00 amRNSFurther Regarding Havelet Acquisition
6th Dec 20227:00 amRNSCompletion of Share Purchase Acquisition
17th Nov 20227:00 amRNSFinancial Services Company Acquistion
27th Oct 20227:00 amRNSChange of Adviser
26th Oct 20224:41 pmRNSSecond Price Monitoring Extn
26th Oct 20224:36 pmRNSPrice Monitoring Extension
3rd Oct 20224:40 pmRNSSecond Price Monitoring Extn
3rd Oct 20224:35 pmRNSPrice Monitoring Extension
3rd Oct 20222:06 pmRNSSecond Price Monitoring Extn
3rd Oct 20222:00 pmRNSPrice Monitoring Extension
3rd Oct 202211:06 amRNSSecond Price Monitoring Extn
3rd Oct 202211:01 amRNSPrice Monitoring Extension
30th Sep 20227:00 amRNSHalf-year Report
28th Sep 20227:00 amRNSAppointment as Investment Manager/Insurance Update
12th Sep 20222:06 pmRNSSecond Price Monitoring Extn
12th Sep 20222:00 pmRNSPrice Monitoring Extension
9th Sep 20222:06 pmRNSSecond Price Monitoring Extn
9th Sep 20222:00 pmRNSPrice Monitoring Extension
8th Sep 20227:00 amRNSDirector and Personnel Announcement
3rd Aug 20227:00 amRNSHolding(s) in Company
26th Jul 20224:40 pmRNSSecond Price Monitoring Extn
26th Jul 20224:35 pmRNSPrice Monitoring Extension
20th Jun 20224:03 pmRNSResults of the Annual General Meeting
31st May 20227:00 amRNSRelease of 2021 Annual Report
27th Apr 20227:00 amRNSShareholder Information Update
24th Mar 20224:41 pmRNSSecond Price Monitoring Extn
24th Mar 20224:36 pmRNSPrice Monitoring Extension
24th Mar 20222:05 pmRNSSecond Price Monitoring Extn
24th Mar 20222:00 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.